Top videos

History Bit: High Priests' Lineage and Its 1st Century Corruption
History Bit: High Priests' Lineage and Its 1st Century Corruption Voice of Messiah Ministries 76 Views • 3 months ago

Donate By "Zelle" Using the Email Below:
Email: bimci777@gmail.com

Don't Have "Zelle"? Use "Paypal" on the Website Below:
"www.nimmi.20m.com"

About Us..........
We are a ministry concerned about the lives of people being made whole and believe that the Most High has raised us up to perpetuate the ministry vision of Yahshua (commonly called "Jesus") the Messiah to make disciples of all nations (ethnic people groups).  We believe that it is essential that all believers be taught the following three things: 

1) The Roots of the Faith in Messiah - To know where we came from 
2) The Future Destiny to Rule with Messiah - To know where we are going
3) To observe ALL that Messiah has commanded - To stay on course until we reach our destiny in Messiah

About the Ministry..........
BIMCI focuses on teaching the Scriptures from its original 1st century Hebraic perspective to this 21st century generation. We use terms such as Yahshua HaMashiach, YHWH (we pronounce as "Yahuah") , Baruch HaShem (Bless the Name), Elohim (the High One or The Most High), Torah (instructions, precepts and teaching), Shabbat (Sabbath), etc... all examples of phrases that were actually spoken by our Messiah and his disciples during the 1st century in Israel. We believe that the emphasis on the Biblical/Hebrew roots of our faith brings enrichment to the Scriptures and preserves the core meaning of its message. Ministry Vision Scripture reveals that the Messianic Israelite Community has been given the charge to continue the ministry of Yahshua the Messiah in the earth. This is characterized by: 

*  Declaring the message of the Kingdom Of Elohim
*  Making disciples of all people 
*  Equipping the believer to do the work of ministry 
*  Ministering to the needs of the afflicted, disadvantaged, imprisoned, & the spiritually weakened to bring them to a place of wholeness

Website:
http://www.ncmmi.20m.com

Mailing Addresses:
Beth Israel Messianic Community Int'l
Dauid Ben Israel, Overseer
4040 Tyler Street, #10a Tacoma, WA. 98409

Phone: (951) 704-2831

Email: bimci777@gmail.com

The power of the pharmaceutical companies _ DW Documentary
The power of the pharmaceutical companies _ DW Documentary Brother T 75 Views • 5 years ago

⁣How much is a human life worth? An innovative cancer therapy promises to save lives. But it is extremely expensive. Will the insurance companies pay for it? What is the manufacturer's return on investment? And do lobbyists drive up prices? In 2018, the Kymriah gene therapy was approved in Europe. Immune cells are taken from the patient, genetically reprogrammed into cancer killer cells, and returned to the patient as an infusion. The results of the Kymriah study only cover a period of 18 months. In 40 percent of patients, lymph gland cancer does not return during this time. It is not clear whether Kymriah has a long-term effect. The Swiss pharmaceutical company Novartis offers the new therapy - it costs 370,000 Swiss francs per patient. Health insurance companies are not usually prepared to pay that much and are complaining about a lack of transparency. But the killer cells were not invented in the Novartis laboratories, but at a US university. When Professor Carl June started his research almost 30 years ago, no pharmaceutical company was interested. It was only thanks to funding from tax money and donations that he was able to develop Kymriah at all. After a story went around the world about a girl with leukemia whose cancer disappeared thanks to Kymriah, the pharmaceutical company contacted Novartis and secured exclusive marketing rights. To launch Kymriah on the market, Novartis funded the necessary clinical trials. It's not an isolated incident: Over 60% of newly approved medicines in the US are developed by small biotech companies or universities. Pharmaceutical companies today frequently act as capital providers, cooperating with universities or buying up biotech companies. A paradigm shift has taken place in the pharmaceutical industry: Whereas high drug prices used to be justified by research costs, the industry is now using the value of gained lifetime to argue its case.

Showing 111 out of 112